Cargando…
P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430175/ http://dx.doi.org/10.1097/01.HS9.0000847784.97005.7a |
| _version_ | 1784779681436794880 |
|---|---|
| author | Vassilakopoulos, T. Piperidou, A. Mellios, Z. Verigou, E. Kalpadakis, C. Katodritou, E. Papageorgiou, S. Chatzidimitriou, C. Giatra, C. Leonidopoulou, T. Xanthopoulos, V. Karakatsanis, S. Gainaru, G. Vrakidou, E. Koumarianou, A. Hatzimichael, E. Verrou, E. Tsirogianni, M. Drandakis, I. Lefaki, M. A. Liaskas, A. Kopsaftopoulou, A. Lampropoulou, P. Kanellias, N. Zikos, P. Liapi, D. Karianakis, G. Grentzelias, D. Papadaki, E. Siakantaris, M. Tsirigotis, P. Panitsas, F. Plata, E. Bakiri, M. Datseris, I. Chatziioannou, S. Prassopoulos, V. Skoura, E. Angelopoulou, M. Symeonidis, A. Karmiris, T. Rontogianni, P. |
| author_facet | Vassilakopoulos, T. Piperidou, A. Mellios, Z. Verigou, E. Kalpadakis, C. Katodritou, E. Papageorgiou, S. Chatzidimitriou, C. Giatra, C. Leonidopoulou, T. Xanthopoulos, V. Karakatsanis, S. Gainaru, G. Vrakidou, E. Koumarianou, A. Hatzimichael, E. Verrou, E. Tsirogianni, M. Drandakis, I. Lefaki, M. A. Liaskas, A. Kopsaftopoulou, A. Lampropoulou, P. Kanellias, N. Zikos, P. Liapi, D. Karianakis, G. Grentzelias, D. Papadaki, E. Siakantaris, M. Tsirigotis, P. Panitsas, F. Plata, E. Bakiri, M. Datseris, I. Chatziioannou, S. Prassopoulos, V. Skoura, E. Angelopoulou, M. Symeonidis, A. Karmiris, T. Rontogianni, P. |
| author_sort | Vassilakopoulos, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430175 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94301752022-08-31 P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS Vassilakopoulos, T. Piperidou, A. Mellios, Z. Verigou, E. Kalpadakis, C. Katodritou, E. Papageorgiou, S. Chatzidimitriou, C. Giatra, C. Leonidopoulou, T. Xanthopoulos, V. Karakatsanis, S. Gainaru, G. Vrakidou, E. Koumarianou, A. Hatzimichael, E. Verrou, E. Tsirogianni, M. Drandakis, I. Lefaki, M. A. Liaskas, A. Kopsaftopoulou, A. Lampropoulou, P. Kanellias, N. Zikos, P. Liapi, D. Karianakis, G. Grentzelias, D. Papadaki, E. Siakantaris, M. Tsirigotis, P. Panitsas, F. Plata, E. Bakiri, M. Datseris, I. Chatziioannou, S. Prassopoulos, V. Skoura, E. Angelopoulou, M. Symeonidis, A. Karmiris, T. Rontogianni, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430175/ http://dx.doi.org/10.1097/01.HS9.0000847784.97005.7a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Vassilakopoulos, T. Piperidou, A. Mellios, Z. Verigou, E. Kalpadakis, C. Katodritou, E. Papageorgiou, S. Chatzidimitriou, C. Giatra, C. Leonidopoulou, T. Xanthopoulos, V. Karakatsanis, S. Gainaru, G. Vrakidou, E. Koumarianou, A. Hatzimichael, E. Verrou, E. Tsirogianni, M. Drandakis, I. Lefaki, M. A. Liaskas, A. Kopsaftopoulou, A. Lampropoulou, P. Kanellias, N. Zikos, P. Liapi, D. Karianakis, G. Grentzelias, D. Papadaki, E. Siakantaris, M. Tsirigotis, P. Panitsas, F. Plata, E. Bakiri, M. Datseris, I. Chatziioannou, S. Prassopoulos, V. Skoura, E. Angelopoulou, M. Symeonidis, A. Karmiris, T. Rontogianni, P. P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS |
| title | P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS |
| title_full | P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS |
| title_fullStr | P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS |
| title_full_unstemmed | P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS |
| title_short | P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS |
| title_sort | p1230: pet/ct imaging for response assessment and treatment guidance after rituximab-dose-adjusted-epoch(r-da-epoch) in primary mediastinal large b-cell lymphoma (pmlbcl):the greek experience on 107 patients |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430175/ http://dx.doi.org/10.1097/01.HS9.0000847784.97005.7a |
| work_keys_str_mv | AT vassilakopoulost p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT piperidoua p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT melliosz p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT verigoue p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT kalpadakisc p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT katodritoue p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT papageorgious p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT chatzidimitriouc p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT giatrac p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT leonidopoulout p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT xanthopoulosv p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT karakatsaniss p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT gainarug p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT vrakidoue p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT koumarianoua p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT hatzimichaele p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT verroue p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT tsirogiannim p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT drandakisi p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT lefakima p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT liaskasa p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT kopsaftopouloua p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT lampropouloup p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT kanelliasn p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT zikosp p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT liapid p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT karianakisg p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT grentzeliasd p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT papadakie p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT siakantarism p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT tsirigotisp p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT panitsasf p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT platae p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT bakirim p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT datserisi p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT chatziioannous p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT prassopoulosv p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT skourae p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT angelopouloum p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT symeonidisa p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT karmirist p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients AT rontogiannip p1230petctimagingforresponseassessmentandtreatmentguidanceafterrituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclthegreekexperienceon107patients |